Assessment of a dual regulatory role for NO in liver regeneration after partial hepatectomy:: protection against apoptosis and retardation of hepatocyte proliferation

被引:24
作者
Zeini, M
Hortelano, S
Través, PG
Gómez-Valdés, AG
Pujol, A
Perales, JC
Bartrons, R
Boscá, L
机构
[1] Univ Complutense, Fac Farm, Inst Bioquim, CSIC,Ctr Mixto, E-28040 Madrid, Spain
[2] Univ Complutense, Fac Farm, Ctr Nacl Invest Cardiovasc, E-28040 Madrid, Spain
[3] Univ Barcelona, Dept Ciencies Fisiol 2, Barcelona, Spain
[4] Univ Autonoma Barcelona, Ctr Biotecnol Anim & Terapia Genica, Unidad Anim Transgen, E-08193 Barcelona, Spain
关键词
nitric oxide synthase; transgenic; gene therapy;
D O I
10.1096/fj.04-3233fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The role of hepatic nitric oxide (NO) in liver regeneration after partial hepatectomy (PH) was studied in animals carrying a nitric oxide synthase-2 transgene under the control of the phospho(enol)pyruvate carboxykinase promoter. These mice expressed NOS-2 in liver cells under fasting conditions. Liver mass recovery and molecular parameters related to cell proliferation were determined after PH. Preexisting hepatic NO synthesis, as well as NO delivery by NO-donors, impaired early signaling (for example, attenuated NF-kappa B activation and TNF-alpha. and IL-6 release). The regenerative process was also impaired as a result of an insufficient proliferative response, but mouse survival after surgery was not compromised. However, NO exerted a protective role against apoptosis in transgenic hepatectomized mice. Local production of NO in liver cells, achieved by hydrodynamic-based transfection with a NOS-2-encoding plasmid, also resulted in delayed liver recovery after PH and also protected against Fas-mediated apoptosis. These data show that sustained presence of NO after PH exerts a dual role: attenuating liver regeneration while efficiently protecting against liver apoptosis.
引用
收藏
页码:995 / +
页数:17
相关论文
共 37 条
  • [1] Interleukin 6 is important for survival after partial hepatectomy in mice
    Blindenbacher, A
    Wang, XY
    Langer, I
    Savino, R
    Terracciano, L
    Heim, MH
    [J]. HEPATOLOGY, 2003, 38 (03) : 674 - 682
  • [2] Bohlinger I, 1995, HEPATOLOGY, V22, P1829, DOI 10.1016/0270-9139(95)90212-0
  • [3] IL-6, a key cytokine in liver regeneration - Comments
    Clavien, PA
    [J]. HEPATOLOGY, 1997, 25 (05) : 1294 - 1296
  • [4] Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice
    Cressman, DE
    Greenbaum, LE
    DeAngelis, RA
    Ciliberto, G
    Furth, EE
    Poli, V
    Taub, R
    [J]. SCIENCE, 1996, 274 (5291) : 1379 - 1383
  • [5] CRESSMAN DE, 1995, HEPATOLOGY, V21, P1443, DOI 10.1016/0270-9139(95)90068-3
  • [6] CRESSMAN DE, 1994, J BIOL CHEM, V269, P30429
  • [7] CYTOKINE-PROCESSING ENZYMES - STOPPING THE CUTS
    DINARELLO, CA
    MARGOLIS, NH
    [J]. CURRENT BIOLOGY, 1995, 5 (06) : 587 - 590
  • [8] Liver regeneration
    Fausto, N
    [J]. JOURNAL OF HEPATOLOGY, 2000, 32 : 19 - 31
  • [9] An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity
    Fiorucci, S
    Mencarelli, A
    Palazzetti, B
    Del Soldato, P
    Morelli, A
    Ignarro, LJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) : 2652 - 2657
  • [10] Higgins GM, 1931, ARCH PATHOL, V12, P186